المؤلفون: Anouk E. J. Latenstein (8450598), Tara M. Mackay (5800568), Geert-Jan Creemers (835883), Casper H. J. van Eijck (5800577), Jan Willem B. de Groot (8450601), Nadia Haj Mohammad (6502591), Marjolein Y. V. Homs (8450604), Hanneke W. M. van Laarhoven (7046744), I. Quintus Molenaar (3615545), Bert-Jan ten Tije (8450607), Judith de Vos-Geelen (5800574), Marc G. Besselink (4109815), Lydia G. M. van der Geest (8450610), Johanna W. Wilmink (4613464)

مصطلحات موضوعية: Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Environmental Sciences not elsewhere classified, randomized trials led, new chemotherapeutic regimens, multilevel logistic regression, methods :, cox regression analyses, conclusion :, background :, 2007 – 2016, 2007 – 2011, p >< b, results :, 4 months (<, paclitaxel varied widely, 60 %, gemcitabine, 2015 – 2016, p <, results emphasize, positive results, 8 months, respectively ), overall survival, median 8, hospital characteristics

Relation: https://figshare.com/articles/dataset/Implementation_of_contemporary_chemotherapy_for_patients_with_metastatic_pancreatic_ductal_adenocarcinoma_a_population-based_analysis/11854743

الاتاحة: https://doi.org/10.6084/m9.figshare.11854743

المؤلفون: Andrzej Piwowar, Fransje Aa Valster, Jeffrey P.B.M. Braak, Marije Ie Appels, Frits van Coevorden, Niels H Nielsen, Johanna E.A. Portielje, Jeroen Buijsen, Petra Flygare, Marije Slingerland, Nicole C.T. van Grieken, Jetske M. Meerum Terwogt, Maartje Los, Mattias Elmlund, Henk Boot, Rob L. H. Jansen, Johanna W. van Sandick, A. Haringhuizen, Johannes J. Bonenkamp, Harm van Tinteren, Edwin P.M. Jansen, Henk H. Hartgrink, Jaap De Boer, Anouk K. Trip, Ge Jpm Jonkers, Marie Louise Jespersen, Cecillia Lagerbäck, Per Edlund, Marco B Polée, Mats Perman, J (Hans)-Martin Mb Otten, Marjan A Van Dijk, Danny Houtsma, A (Bert) Jan Ten Tije, Arnold Baars, Olaf Jl Loosveld, Maud M. Geenen, Maarten C.C.M. Hulshof, Gerrit-Jan Veldhuis, Erik W Muller, Geert-Jan Creemers, Annelie Je Vulink, Quirijn A. J. Eijsbouts, Annerie Slot, Diane Grootenboers, Hein Putter, Ellen M Hendriksen, Maurice J.C. van der Sangen, Fabiënne A. R. M. Warmerdam, Tom Rozema, HA A. Maurits Swellengrebel, Henk K Van Halteren, Ate van der Gaast, Marcel Verheij, Richard Van Hilligersberg, Helene Hörberg, Pehr Lind, Annemieke Cats, Cornelis J.H. van de Velde, Jitty M Smit, Alex L. T. Imholz, Donald L. van der Peet, Aart Van Bochove, Henk M.W. Verheul, Adelheid Me Van der Torren-Conze, Frans L. G. Erdkamp, Dick Johan van Spronsen, Mark I. van Berge Henegouwen, Ernst Jan Spillenaar Bilgen, Johanna Mgh Van Riel, Marien O Den Boer, Hanneke W. M. van Laarhoven, Marjolein Em Rentinck, Ron C Rietbroek, Bengt Johansson, David Borg, Anders Johnsson, Aart Beeker, Reinoud J. B. Blaisse, Miriam Koopman, Daan Ten Bokkel Huinink, Karen J. Neelis, Elma Meershoek-Klein Kranenbarg, Djamila Boerma, Heleen M. Ceha, Bea C Tanis, Marie-Cecile Jc Legdeur, O Aart Van Dobbenburgh, Steven Vanhoutvin, Sjoerd Hovenga, Karolina Sikorska, Pètra M Braam, H Pieter van den Berg, Huub van der Mijle, Marianne Nordsmark, Bengt Glimelius

المساهمون: Oncology, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and Quality of Life, Surgery, Radiotherapy, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Medische Oncologie (9), Interne Geneeskunde, Pathology, CCA - Cancer Treatment and quality of life, VU University medical center, Radiation Oncology, AGEM - Digestive immunity, Medical oncology, Plastic, Reconstructive and Hand Surgery

المصدر: lancet oncology, 19(5), 616-628. Lancet Publishing Group
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet Oncology, 19, 5, pp. 616-628
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS)-an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet oncology, 19(5), 616-628. Elsevier Science
Lancet Oncology, 19, 616-628
The Lancet Oncology, 19(5), 616-628
The Lancet Oncology, 19(5), 616-628. Lancet Publishing Group

مصطلحات موضوعية: Male, 0301 basic medicine, Time Factors, medicine.medical_treatment, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, I-II, education.field_of_study, Middle Aged, Neoadjuvant Therapy, Progression-Free Survival, Europe, GASTROESOPHAGEAL JUNCTION, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Epirubicin, medicine.drug, medicine.medical_specialty, Population, Adenocarcinoma, Sudden death, Medication Adherence, CISPLATIN, 03 medical and health sciences, Gastrectomy, Stomach Neoplasms, medicine, DOSE-ESCALATION, Humans, Progression-free survival, CAPECITABINE CHEMOTHERAPY, education, Aged, Neoplasm Staging, Chemotherapy, III TRIAL, Performance status, business.industry, PERIOPERATIVE CHEMOTHERAPY, Chemoradiotherapy, Adjuvant, Surgery, Oxaliplatin, 030104 developmental biology, NODAL DISSECTION, Quality of Life, Lymph Node Excision, Dose Fractionation, Radiation, business, POSTOPERATIVE CHEMORADIOTHERAPY, Chemoradiotherapy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b21019f3b155741c37a17771cdb957cb
https://pure.amc.nl/en/publications/chemotherapy-versus-chemoradiotherapy-after-surgery-and-preoperative-chemotherapy-for-resectable-gastric-cancer-critics-an-international-openlabel-randomised-phase-3-trial(8c4f223a-519d-480e-ad66-3d7eaea704e6).html

المؤلفون: Bengt Glimelius, Esmée A Dijkstra, Geke A. P. Hospers, Corrie A.M. Marijnen, Annet G H Roodvoets, Cornelis J.H. van de Velde, Per Nilsson, Derk Jan A. de Groot, Hein Putter, Andrés Cervantes, Tone Fokstuen, Jaume Capdevila, Mathijs P. Hendriks, Boudewijn van Etten, Collaborative Investigators Rapido Trial, Maxime J M van der Valk, Elma Meershoek – Klein Kranenbarg, Denise E. Hilling, Bert Jan ten Tije, Ibrahim Edhemovic

المصدر: European Journal of Surgical Oncology. 46:e20

مصطلحات موضوعية: Chemotherapy, medicine.medical_specialty, Colorectal cancer, business.industry, medicine.medical_treatment, General Medicine, medicine.disease, Acute toxicity, Surgery, Compliance (physiology), Oncology, medicine, business, Short course radiotherapy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::846fec792d0d5c6faccd851e60413638
https://doi.org/10.1016/j.ejso.2019.11.472

المؤلفون: Ismail, Rawa K., Sikkes, Nienke O., Wouters, Michel W. J. M., Hilarius, Doranne L., Pasmooij, Anna M. G., van den Eertwegh, Alfonsus J. M., Aarts, Maureen J. B., van den Berkmortel, Franchette W. P. J., Boers-Sonderen, Marye J., de Groot, Jan Willem B., Haanen, John B. A. G., Hospers, Geke A. P., Kapiteijn, Ellen, Piersma, Djura, van Rijn, Roos S., Suijkerbuijk, Karijn P. M., Bert-Jan ten Tije, van der Veldt, Astrid A. M., Vreugdenhil, Art, van Dartel, Maaike

المصدر: Melanoma Research; Feb2021, Vol. 31 Issue 1, p58-66, 9p